Eventide Asset Management - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$2,325,000
-10.3%
150,0000.0%0.14%
-15.7%
Q1 2017$2,591,000
+57.1%
150,0000.0%0.17%
+60.7%
Q4 2016$1,649,000
-29.9%
150,0000.0%0.11%
-25.7%
Q3 2016$2,352,000
+53.5%
150,0000.0%0.14%
+53.2%
Q2 2016$1,532,000
-20.8%
150,0000.0%0.09%
-13.0%
Q1 2016$1,935,000
-7.3%
150,000
+50.0%
0.11%
+3.8%
Q4 2015$2,087,000100,0000.10%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,450,000$8,320,5001.17%
BVF INC/IL 6,595,801$8,508,5830.23%
Bronte Capital Management Pty Ltd. 925,245$1,193,5660.12%
Formidable Asset Management, LLC 318,111$410,3630.09%
Congress Park Capital LLC 112,450$145,0610.08%
Forefront Analytics, LLC 49,421$63,7540.04%
Ground Swell Capital, LLC 10,966$14,1460.02%
Clearline Capital LP 196,583$253,5920.02%
CORNERCAP INVESTMENT COUNSEL INC 81,352$104,9440.02%
ACADIAN ASSET MANAGEMENT LLC 2,646,190$3,4120.01%
View complete list of CYTOMX THERAPEUTICS INC shareholders